AP
IDXX icon

Arlington Partners’s Idexx Laboratories IDXX Stock Holding History

Arlington Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15
Closed -$6.56K – 297
2023
Q3 		$6.56K Sell
15
-35
-70% -$17.5K ﹤0.01% 251
2023
Q2 		$25.1K Buy
50
+35
+233% +$16.8K ﹤0.01% 371
2023
Q1 		$7.5K Buy
+15
New +$7.18K ﹤0.01% 439
2022
Q1 		– Sell
-4
Closed -$3K – 545
2021
Q4 		$3K Buy
+4
New +$2.51K ﹤0.01% 612

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arlington Partners's IDXX Position: Q4 2023 in Review

Arlington Partners sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 15 shares — an estimated $6.56K sold.

Arlington Partners first reported a position in IDXX in Q4 2021 and held it in 4 quarters. The position peaked at $25.1K in Q2 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Arlington Partners reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Arlington Partners sold 15 Idexx Laboratories shares in Q4 2023, an estimated $6.56K.
  • Arlington Partners first reported a position in Idexx Laboratories in Q4 2021 and held it in 4 quarters.
  • Arlington Partners's Idexx Laboratories position peaked at $25.1K in Q2 2023.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Arlington Partners's 13F filing for Q4 2023, filed 24 Jan 2024.